Ocular fluorophotometry has developed over several years into a valuable technique in ophthalmological clinical research. It has several uses and has established itself in the investigation of blood-aqueous barriers", blood-retinal barriers", aqueous flow measurements'', corneal endothelial permeability", and tear flow dynamics''. Vitreous fluorophotometry is mainly applied to diseases of the retina, choroid and vitreous.
Introduction
Ocular fluorophotometry has developed over several years into a valuable technique in ophthalmological clinical research. It has several uses and has established itself in the investigation of blood-aqueous barriers", blood-retinal barriers", aqueous flow measurements'', corneal endothelial permeability", and tear flow dynamics''. Vitreous fluorophotometry is mainly applied to diseases of the retina, choroid and vitreous.
Ocular fluorophotometry is a technique whereby degrees of fluorescence are measured throughout the eye at certain defined and reproducible points, before and after the application of sodium fluorescein. The degree of fluorescence detected is a function of the amount of fluorescein present.
Fluorophotometry relies on the fact that fluorescein enters the diseased eye in larger quantities and at a faster rate than it enters the healthy normal eye. For fluorescein, and indeed, for any substance to leak into the eye, it must pass throughout the blood-ocular barriers first. These are made up ofthe blood-retinal and the blood-aqueous barriers.
Vitreous fluorophotometry is mainly concerned with the blood-retinal barrier which is found at the tight junctions of the pigment epithelial cells of the retina'' and the endothelial cells of the retinal capillaries". These barriers must be disturbed to allow abnormal amounts of substances into the eye. Fluorophotometry is therefore a method of assessing the integrity of these barriers to fluorescein. Measurements are reproducible and' quantifiable and the technique particularly lends itself to longitudinal studies.
Instrumentation
The Fluorotron Master" (Coherent, Palo Alto, California) is probably the most common type of fluorophotometer in use today (Figure 1 ), its main advantage over most other types offluorophotometers being that it does not require a contact lens placed on the eye for measurements. A blue exitation light is delivered through the optics of the system to the eye and the resulting emitted fluorescent light is collected via the same optical system. Where the exiting and the emitted rays intersect in the eye there is produced a measurement volume known as the focal diamond. It is within this focal diamond that levels of fluorescence are measured, and the focal diamond is automatically moved along the axis of the eye from behind the retina to in front of the cornea (Figure 2 ). The movement of the diamond occurs in steps of 0.25 mm, and at each position a measurement of fluorescence is taken. The level of fluorescence detected at each point is then automatically plotted against distance away from the retina to produce a scan for the eyes. .i1
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Technique
The method of fluorophotometry entails dilating the -pupils and also producing cycloplegia. All measurements are taken in darkness and scans are performed on one eye at a time ( Figure 3 ). A baseline background (pre-injection) scan is performed to assess the natural autofluorescence of the eye. Sodium fluorescein is then injected intravenously in a dose of 14 mg/kg/body weight. Conventional fundus fluorescein angiography is then performed but at around 3-5 min a further scan, the bolus scan, is performed. A final scan, the measurement scan, is performed at 60 min.
It is desirable to know the levels of fluorescein in the plasma over the period that the scans are performed. This naturally affects the amount of fluorescein available to penetrate the blood-ocular barriers. Venepuncture is therefore performed between 2 and 8 times over the period of 60 min and the exact times are recorded.
Analysis Table 1 shows some of the factors which can influence the levels of fluorescence detected in the vitreous. Analysis of the scans is necessary to minimize any artifacts that may appear in the scans", The tissues of the eye, particularly the lens, autofluoresce to a certain degree and will affect any measurement. Also light scattering within the eye can reduce the sensitivity of the measurement. Elimination of these possible sources of error is generally performed in one of two ways. The first method simply entails subtracting the pre-injection background scan from the measurement scan and is suitable for cases oflow leakage of fluorescein. The other method, often used in cases of higher fluorescein leakage, is known as 'optimization'. This method entails subtracting the background and the bolus scan from the measurement scan to correct for signal spread which may occur from the limited axial resolution of the instrument. This produces a further scan, the optimized scan, which can be conveniently divided into different regions, namely: posterior, middle and anterior vitreous (Figure 3) , for further detailed analysis. The fluorescence detected in the posterior vitreous compartment or at a distance of 3 mm anterior to the retina is usually specified in published articles.
For more accurate measurements the concentration of fluorescein in the blood should be taken into account. At present investigators are divided as to whether concentrations should be measured on plasma ultrafiltrate (free unbound fluorescein) or whole (free and bound fluorescein) plasma. Fluorescein is approximately 85% bound to plasma protein!", The plasma values are incorporated into a computer algorithm to attain the plasma fluorescein integral which reflects the amount of fluorescein to which the blood ocular barriers are exposed over the period of the examination. The posterior vitreous fluorescein concentration is divided by the integral of the plasma fluorescence to obtain a final posterior vitreous penetration ratio!', or similar permeability index-", for the eye. This value reflects the amount of fluorescein that has penetrated the posterior vitreous for a given amount of fluorescein that has circulated, over time, in the blood.
Recently, in attempts to further increase the sensitivity of the technique, investigators have paid attention to the fact that fluorescein is converted by conjugation into metabolites, namely a monoglucuronide, when in vivo 13 • This metabolite only fluoresces between 5 and 10% the intensity of the orginal dye 14 • Again, measurement of free or bound metabolite is disputed amongst investigators. There is no simple method at present to assess the contribution of each component to the total fluorescence.
Clinical findings
Probably the first disease to be assessed was diabetes mellitus. There is breakdown of the blood-retinal barrier in diabetic retinopathy and the severity of this breakdown increases as the severity of the retinopathy, age of the patient, and duration of the disease, all increase-s, This applies to insulin" and non-insulin dependent diabetes'", and also secondary diabetes". Poor metabolic control of the diabetes results in breakdown of the blood-retinal barrier which is reversible with better control. Some investigators have shown abnormally high vitreous fluorophotometric readings in diabetic patients without any detectable retinopathy even by fluorescein angiography'". However, others have found this not to be the case 20 and there is still some controversy over this point. As the procedure is quantifiable and reproducible it is possible to follow the progress of any retinopathy and also monitor the effect of certain types of treatment on this progress.
Subjects with retinitis pigmentosa have breakdown of the blood-retinal barrier, and the amount of fluorescein within the vitreous correlates well with the extent of photoreceptor and retinal pigment epithelial disease'", Fluorophotometry has been extended to carriers of x-linked retinitis pigmentosa and they have been shown to have high leakage of fluorescein into the vitreous. This leakage correlates well with the abnormality found on ophthalmoscopy, visual field testing and electrodiagnostically. It has also been shown that some carriers with no other detectable abnormality, either clinically or electrodiagnostically, may have a compromised blood-retinal barrier and this test may be a useful addition to our armamentarium in the diagnosis of these patients 22 • Cystoid macular oedema occurs with breakdown of the blood-retinal barrier and is identified by increased levels of fluorescence by fluorophotometry-", All patients have breakdown of the blood-ocular barriers following cataract surgery. This is usually subclinical and asymptomatic. However, it appears that there is increased severity of breakdown of the blood-ocular barriers following intracapsular cataract extraction as compared with extracapsular cataract extraction-s. Reformation of the barriers also takes longer with intracapsular techniques and may take up to 3 years to return to normal'", There is increased disturbance of the barrier with increased age ofthe patient at the time of cataract extraction. Macular oedema as a result of the vitreous wick syndrome demonstrates breakdown of the blood-retinal barrier, and shows improvement following anterior vitrectomy and release of traction'", Journal of the Royal Society of Medicine Volume 81 July 1988 405
Chronic inflammatory diseases such as pars planitis show breakdown of the blood-retinal barrier. The leakage of fluorescein is generalized in the posterior segment and the fluorophotometric readings correlate well with the amount of macular oedema presents". Both laser photocoagulation and cryotherapy of the retina result in disruption of the blood-retinal barrier-", The extent of the disruption is generally more severe with cryotherapy, but depends on the amount of retina being treated. The barrier can reform in approximately 14 days following xenon photocoagulation-", In systemic hypertension with active retinopathy (i.e. haemorrhages, exudates, and cotton wool spots) there is breakdown of the blood-retinal barrier-". The high fluorophotometric readings may diminish with treatment of the hypertension especially if it is of short duration!'. Vitreous fluorophotometry has also been performed in various other conditions. The bloodretinal barrier is normal in familial drusen, fundus albipunctatus, Stargardt's disease and fundus flavimaculatus despite histological lesions being present at the level of the outer blood retinal barrier or pigment epithelium 31 ,32. Breakdown ofthe barrier occurs in gyrate atrophy and choroideraemia, but not in patients with congenital stationary night blindness 31 ,33. Patients with acute episodes of retrobulbar neuritis may show elevated fluorophotometric readings" despite normal fluorescein angiography and this may also occur in those with multiple sclerosis with ocular involvement.". Neovascularization, either retinal, i.e. sickle cell retinopathy'", or subretinal, i.e. senile macular degeneration'", demonstrates high fluorophotometric readings. Drusen alone appear not to affect the barrier. Toxic retinopathy can be detected by fluorophotometry and we have recently demonstrated that there is breakdown of the blood-retinal barrier in established cases of chloroquine toxicity. Pigmented choroidal lesions may be difficult to differentiate between benign and malignant types clinically. We have recently shown that there is breakdown of the blood-retinal barrier in cases of clinical malignant melanoma. We have compared these findings with other pigmented lesions such as benign choroidal naevi and found normal leakage levels. It may be that vitreous fluorophotometry has a role in differentiating these two conditions.
The blood-retinal barrier has still not been quantitatively studied in many ocular conditions in vivo.
Vitreous fluorophotometry offers this ability but is still a research technique at present. It may help us to understand retinal diseases in more depth and to assess the effect of certain treatments on some of these diseases. Perhaps it will soon become a useful routine investigation in the clinical setting.
